| Trial ID: | L6494 |
| Source ID: | NCT00409461
|
| Associated Drug: |
Atg-Sirolimus-Tacrolimus
|
| Title: |
Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Islet Transplantation|Type 1 Diabetes
|
| Interventions: |
DRUG: ATG-Sirolimus-Tacrolimus
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: AZ-VUB | Collaborators: Fund for Scientific Research, Flanders, Belgium|Belgian Government
|
| Gender: |
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose:
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-12-11
|
| Locations: |
Academisch Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB, Brussels, 1090, Belgium|Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL, Leuven, 3000, Belgium
|
| URL: |
https://clinicaltrials.gov/show/NCT00409461
|
